Cargando…

Metabolic disturbances encountered during pediatric continuous renal replacement therapy

Detalles Bibliográficos
Autores principales:	Soysal, D, Nayir, A, Karabocuoglu, M, Citak, A, Ucsel, R, Uzel, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092658/ http://dx.doi.org/10.1186/cc4630

Ejemplares similares

Maintenance fluids should contain at least 77 mmol sodium per liter for critically ill pediatric patients
por: Karabocuoglu, M, et al.
Publicado: (2006)

Airway pressure release ventilation: an alternative ventilation mode for pediatric acute respiratory distress syndrome
por: Demirkol, D, et al.
Publicado: (2008)

Acute transfusion reactions in critically ill pediatric patients
por: Ozata, N, et al.
Publicado: (2008)

Comparison of vasoactive medications and investigation determinants of mortality in children
por: Demirkol, D, et al.
Publicado: (2008)

Acute liver failure in children in Istanbul University: retrospective analysis of 30 cases
por: Süoglu, Ö, et al.
Publicado: (2006)

Comparison of prognostic scores at a pediatric ICU
por: Soysal, D, et al.
Publicado: (2006)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Therapeutic plasma exchange in children with acute liver failure: assessment of laboratory parameters
por: Demirkol, D, et al.
Publicado: (2010)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Protein content with parenteral nutrition in critical and hospitalized patients with continuous renal replacement therapies
por: Baez, AV, et al.
Publicado: (2015)

Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience
por: Turani, F, et al.
Publicado: (2013)

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)

Daily fluid balance predicts hospital mortality in critically ill patients receiving continuous renal replacement therapy
por: Kashiouris, M, et al.
Publicado: (2013)

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
por: Shum, HP, et al.
Publicado: (2012)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Systemic citrate load during continuous renal replacement therapy is not negligible and can be predicted using indirect methods
por: Zakharchenko, M, et al.
Publicado: (2011)

Evaluation of functional differences between two anticoagulation methods used in continuous renal replacement therapy in critical patients
por: Goulão, V, et al.
Publicado: (2014)

Timing of the initiation of continuous renal replacement therapy and clinical outcome in patients with severe sepsis and septic shock
por: Cho, S
Publicado: (2012)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Utilization of slow low-efficiency dialysis may help to optimize the need for continuous renal replacement therapy in Indian ICUs
por: Majumdar, A, et al.
Publicado: (2009)

Weight gain a risk factor for mortality in patients with acute kidney injury requiring continuous renal replacement therapy
por: Maldonado Toral, C, et al.
Publicado: (2015)

Continuous renal replacement therapy (CVVHD) for acute kidney injury in critical care: incidence and outcome across South West Wales
por: Brown, K, et al.
Publicado: (2014)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

A comparison between 2 dilute citrate solutions (15mmol/l vs 18 mmol/l) in continuous renal replacement therapy: the base excess and renal replacement solution (BEARRS) study
por: Anstey, CM, et al.
Publicado: (2015)

High fluid volume removal with continuous renal replacement therapy as a therapeutic option for early posttraumatic acute respiratory distress syndrome
por: Sorrentino, L, et al.
Publicado: (2008)

Management for Electrolytes Disturbances during Continuous Renal Replacement Therapy
por: Baeg, Song In, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4kc3pceu1gd4s9ta62en1574kn